Veerle Matheeussen
- Oncology top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Molecular Biology
- Cellular and Molecular Neuroscience top 10%
- Epidemiology
- Co-authors
- Ingrid De MeesterWolfgang JungraithmayrLesley BaertsPieter Van der VekenSimon ScharpéKoen AugustynsAnne‐Marie LambeirNelson Gomez
- Topics
- Peptidase Inhibition and Analysis (13 papers)Neuropeptides and Animal Physiology (10 papers)Diabetes Treatment and Management (7 papers)
- Partner nations
- BelgiumUgandaUnited States
In The Last Decade
Veerle Matheeussen
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Oncology 384
- Endocrinology, Diabetes and Metabolism 352
- Molecular Biology 269
- Cellular and Molecular Neuroscience 230
- Epidemiology 167
Countries citing papers authored by Veerle Matheeussen
This map shows the geographic impact of Veerle Matheeussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veerle Matheeussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veerle Matheeussen more than expected).
Fields of papers citing papers by Veerle Matheeussen
This network shows the impact of papers produced by Veerle Matheeussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veerle Matheeussen. The network helps show where Veerle Matheeussen may publish in the future.
Co-authorship network of co-authors of Veerle Matheeussen
This figure shows the co-authorship network connecting the top 25 collaborators of Veerle Matheeussen. A scholar is included among the top collaborators of Veerle Matheeussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veerle Matheeussen. Veerle Matheeussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 17 | |
| 8 | 23 | |
| 9 | 3 | |
| 10 | 97 | |
| 11 | 5 | |
| 12 | 27 | |
| 13 | 11 | |
| 14 | 15 | |
| 15 | 53 | |
| 16 | 91 | |
| 17 | 59 | |
| 18 | 76 | |
| 19 | 7 | |
| 20 | 38 |
About Veerle Matheeussen
Veerle Matheeussen is a scholar working on Molecular Medicine, Infectious Diseases and Endocrinology, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (13 papers), Neuropeptides and Animal Physiology (10 papers) and Diabetes Treatment and Management (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (352 citations), Oncology (384 citations) and Cellular and Molecular Neuroscience (230 citations). Veerle Matheeussen has collaborated with scholars based in Belgium, Uganda and United States. Frequent co-authors include Ingrid De Meester, Wolfgang Jungraithmayr, Lesley Baerts, Pieter Van der Veken, Simon Scharpé, Koen Augustyns, Anne‐Marie Lambeir, Nelson Gomez, Kathleen Mc Entee and Guido R.Y. De Meyer. Their work appears in journals such as Journal of Medicinal Chemistry, Molecules and Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.